產(chǎn)品名稱 |
VCaP |
商品貨號 |
B167164 |
Organism |
Homo sapiens, human |
Tissue |
prostate; derived from metastatic site: vertebral metastasis |
Cell Type |
epithelial |
Product Format |
frozen |
Morphology |
epithelial |
Culture Properties |
adherent |
Biosafety Level |
2 [Cells produce the mouse xenotropic retrovirus Bxv-1]
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Disease |
cancer |
Age |
59 years |
Gender |
male |
Ethnicity |
Caucasian |
Storage Conditions |
liquid nitrogen vapor phase |
Images |
|
Derivation |
This line was established in 1997 from a vertebral bone metastasis from a patient with hormone refractory prostate cancer. It was passaged as xenografts in mice then cultured in vitro. It is androgen sensitive in vitro and in vivo. |
Clinical Data |
59 years
Caucasian
male
|
Antigen Expression |
cytokeratin-18; Homo sapiens, expressed p53 antigen; Homo sapiens, expressed prostate specific antigen (PSA); Homo sapiens, expressed prostatic acid phosphatase (PAP); Homo sapiens, expressed Rb protein; Homo sapiens, expressed |
Genes Expressed |
cytokeratin-18; Homo sapiens, expressed ,p53 antigen; Homo sapiens, expressed ,prostate specific antigen (PSA); Homo sapiens, expressed ,prostatic acid phosphatase (PAP); Homo sapiens, expressed ,Rb protein; Homo sapiens, expressed |
Tumorigenic |
Yes |
Effects |
Yes, in nude and SCID mice |
Comments |
Recently, it has been shown that VCaP prostate cancer cells produce the mouse xenotropic retrovirus Bxv-1, which was likely acquired by the cells during their xenotransplantation in mice.
ATCC® CRL-2876 ™ is a very slow growing cell line and can take up to 48 hours to attach post-thaw and after subcultures. It can routinely take a minimum of 2 weeks or more for cells to reach approximately 50% confluence with a dense mixture of adherent cells, floating clusters and moderate to heavy debris is always present. The cells may recover better in a T-25 flask compared to a T75 flask. Do not discard any floating cells that may be present during medium changes and subcultures. Instead, spin them down using gentle centrifugation and add them back to the adherent population. The cells attach in small tightly formed clusters and some single cells. As the cells attach and start to proliferate and spread, they will grow as flattened epithelial-like islands of tightly packed cells. |
Complete Growth Medium |
The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
Subculturing |
Volumes are given for a 75 cm2 flask. Increase or decrease the amount of dissociation medium needed proportionally for culture vessels of other sizes. Corning® T-75 flasks (catalog #430641) are recommended for subculturing this product.
- Remove and discard culture medium.
-
Briefly rinse the cell layer with Hank's Balanced Salt Solution or 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
-
Add 1.0 to 2.0 mL of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach.
Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
-
Add 6.0 to 8.0 mL of complete growth medium and aspirate cells by gently pipetting.
-
Add appropriate aliquots of the cell suspension to new culture vessels.
An inoculum of 2 X 104 to 4 X 104 viable cells/cm2 is recommended.
- Incubate cultures at 37°C.
Interval: Subculture when the cell concentration reaches between 1 X 105 and 2 X 105 cells/cm2.
Subcultivation Ratio: 1:3 to 1:4 |
Cryopreservation |
Freeze medium: 95% growth medium; 5% DMSO Storage temperature: liquid nitrogen vapor phase |
Culture Conditions |
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Temperature: 37°C |
STR Profile |
Amelogenin: X,Y CSF1PO: 10,12 D13S317: 11,12 D16S539: 9 D5S818: 12 D7S820: 9,12 THO1: 9.3 TPOX: 8,11 vWA: 18,19 |
Population Doubling Time |
about 53 hours |
Name of Depositor |
KJ Pienta |
Passage History |
This line was established in 1997 from a vertebral bone metastasis from a patient with hormone refractory prostate cancer. It was passaged as xenografts in mice then cultured in vitro. It is androgen sensitive in vitro and in vivo. |
Year of Origin |
1997 |
References |
Korenchuk S, et al. VCaP, a cell-based model system of human prostate cancer
. In Vivo 15: 163-168, 2001. PubMed: 11317522
Knouf EC, et al. Multiple integrated copies and high-level production of the human retrovirus XMRV from 22Rv1 prostate carcinoma cells. J. Virol. 83: 7353-7356, 2009. PubMed: 19403664
Sfanos KS, et al. Identification of replication competent murine gamma retroviruses in commonly used prostate cancer cell lines. PLoS One 6:e20874, 2011.
|